Beyondspring Inc
BYSI
NASDAQ
Biotechnology
$0.84
USD
-0.16 (-15.78%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $37.55M
Volume 768.3K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-22.06M
TTM
-80.3%
YoY
Operating Cash Flow
$-18.85M
TTM
-22.6%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 1.7 | 0.9 | 0.8 | 1.1 | 1.2 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 2.6 | 1.9 | 1.8 | 2.6 | 2.2 |
Operating Income | -2.6 | -1.9 | -1.8 | -2.6 | -2.2 |
EBITDA | -2.5 | -1.9 | -1.7 | -2.8 | -2.2 |
Other Income / Expense | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
Total Other Income / Expense | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
Income Before Income Taxes | -2.6 | -1.9 | -1.7 | -2.5 | -2.2 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
Net Income | 1.2 | -4.6 | -4.9 | -5.8 | -6.7 |
Consolidated Net Income / Loss | 1.2 | -1.9 | -1.5 | -15.2 | -6.7 |
Net Income Attributable to Common Shareholders | 4.5 | -1.8 | -1.5 | -2.1 | -2.2 |
Basic EPS | $0.11 | -$0.04 | -$0.04 | -$0.05 | -$0.05 |
Diluted EPS | $0.11 | -$0.04 | -$0.04 | -$0.05 | -$0.05 |
Basic Shares Outstanding | 40.3M | 40.3M | 40.3M | 40.7M | 41.1M |
Diluted Shares Outstanding | 40.3M | 40.3M | 40.3M | 40.7M | 41.1M |